ARCHIVES

Clearinghouse Group Selects 10 More Compounds To Test

This article is from The Cancer Letter archive.

Vol. 04 No. 02 | January 13, 1978

Download PDF Visit The Full Archive

Related Articles

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

Study: Vismodegib Effective Where Surgery is Inappropriate

June 24, 2011

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

Duke Scientists Develop 3D Mammography Using CT

February 24, 2006

DCT Board Approves Recompetition Of Clinical Trials, Other Contracts, New BNCT Grants

October 28, 1988

New Predictive Score May Help In Planning Adjuvant Therapy

September 26, 2008